Discover
VTYX
Ventyx Biosciences Inc
14.00
20 x 13.98
2 x 14.00
bid
ask
+
0.00
0.00%
11 @ 04:00 PM
13.99 -0.01 (0.07%)
| Ytd | 55.04% | |
| 1y | 858.90% |
13.99
day range
14.00
0.78
52 week range
25.00
| Open | 13.99 | Prev Close | 14.00 | Low | 13.99 | High | 14.00 | Mkt Cap | 1.00B |
| Vol | 5.40M | Avg Vol | 3.62M | EPS | -1.49 | P/E | N/A | Forward P/E | -8.94 |
| Beta | 1.27 | Short Ratio | 1.84 | Inst. Own | 84.50% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-05 | 50-d Avg | 13.23 | 200-d Avg | 6.78 | 1yr Est | 13.00 |
| Income Statement | |||
| Operating Expenses | 24.87M | ||
| Research and Development Expense | 17.71M | ||
| Selling, General and Administrative Expense | 7.17M | ||
| Operating Income | -24.87M | ||
| Net Income | -22.83M | ||
| Net Income Common Stock | -22.83M | ||
| Net Income Common Stock (USD) | -22.83M | ||
| Consolidated Income | -22.83M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -22.83M | ||
| Earning Before Interest & Taxes (USD) | -22.83M | ||
| Weighted Average Shares | 71.30M | ||
| Weighted Average Shares Diluted | 71.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 32.95M | ||
| Cash and Equivalents (USD) | 32.95M | ||
| Investments | 160.67M | ||
| Investments Current | 160.67M | ||
| Current Assets | 201.09M | ||
| Property, Plant & Equipment Net | 9.38M | ||
| Total Assets | 211.47M | ||
| Debt Current | 1.18M | ||
| Total Debt | 10.02M | ||
| Current Liabilities | 11.26M | ||
| Debt Non-Current | 8.84M | ||
| Total Liabilities | 20.10M | ||
| Accumulated Retained Earnings (Deficit) | -631.57M | ||
| Accumulated Other Comprehensive Income | 223.00K | ||
| Shareholders Equity | 191.36M | ||
| Shareholders Equity (USD) | 191.36M | ||
| Assets Non-Current | 10.37M | ||
| Total Debt (USD) | 10.02M | ||
| Liabilities Non-Current | 8.84M | ||
| Trade and Non-Trade Payables | 993.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 326.00K | ||
| Net Cash Flow from Financing | 203.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -331.00K | ||
| Capital Expenditure | -50.00K | ||
| Issuance (Purchase) of Equity Shares | 203.00K | ||
| Net Cash Flow from Investing | 17.05M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 17.10M | ||
| Net Cash Flow from Operations | -17.51M | ||
| Effect of Exchange Rate Changes on Cash | -77.00K | ||
| Share Based Compensation | 4.60M | ||